The table below shows Corbus Pharmaceuticals Holdings, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
-
-
-
-
-
-
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$19.82M
$20.86M
$15.19M
$15.64M
$10.81M
$6.87M
SG&A
CRBP annual revenue (10-K history)
Corbus Pharmaceuticals Holdings, Inc. reported annual revenue of $0.00 for fiscal year 2022. That is down 100.0% from $881.71K in fiscal 2021. Over the 8 fiscal years shown, annual revenue declined from $648.38K (FY 2015) to $0.00. Figures come from the company's audited annual reports as filed with the SEC.